Cargando…

Using lesion washout volume fraction as a biomarker to improve suspicious breast lesion characterization

The purpose of this study was to evaluate using lesion washout (WO) volume fraction as a biomarker to improve the characterization of suspicious breast lesions. Study lesions consisted of a total of 60 malignant tumors (BI‐RADS 6) and 62 suspicious lesions (BI‐RADS 4 or 5). The biopsies of these sus...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jie, Schafer, Sarah M., Aben, Gerald R., Hoisington, Lori A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690164/
https://www.ncbi.nlm.nih.gov/pubmed/26699291
http://dx.doi.org/10.1120/jacmp.v16i5.5187
_version_ 1783279545203294208
author Huang, Jie
Schafer, Sarah M.
Aben, Gerald R.
Hoisington, Lori A.
author_facet Huang, Jie
Schafer, Sarah M.
Aben, Gerald R.
Hoisington, Lori A.
author_sort Huang, Jie
collection PubMed
description The purpose of this study was to evaluate using lesion washout (WO) volume fraction as a biomarker to improve the characterization of suspicious breast lesions. Study lesions consisted of a total of 60 malignant tumors (BI‐RADS 6) and 62 suspicious lesions (BI‐RADS 4 or 5). The biopsies of these suspicious lesions resulted in a total of 30 malignant tumors and 32 benign lesions, respectively, yielding a 48.4% positive predictive value (PPV) of the biopsies. The mean and standard deviation of the lesion WO volume fraction of these 60 BI‐RADS 6 malignant tumors were first computed to establish a 99% sensitivity threshold value for malignant tumors, and then the biomarker was used to characterize the suspicious lesions. Using the biomarker would characterize all the malignant tumors as malignant, 12 out of the 32 benign lesions as benign, potentially resulting in a 24% improvement rate in the PPV of the biopsies (from 48.4% to 60%) and consequently a 22.5% reduction rate in the false‐positive rate of benign biopsies (from 51.6% to 40%). The lesion WO volume fraction biomarker could improve the computer‐based assessment of breast MRI by increasing the PPV of breast biopsies and reducing the number of unnecessary biopsies without compromising sensitivity. PACS number: 87.61.Tg, 87.19.Xj
format Online
Article
Text
id pubmed-5690164
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-56901642018-04-02 Using lesion washout volume fraction as a biomarker to improve suspicious breast lesion characterization Huang, Jie Schafer, Sarah M. Aben, Gerald R. Hoisington, Lori A. J Appl Clin Med Phys Medical Imaging The purpose of this study was to evaluate using lesion washout (WO) volume fraction as a biomarker to improve the characterization of suspicious breast lesions. Study lesions consisted of a total of 60 malignant tumors (BI‐RADS 6) and 62 suspicious lesions (BI‐RADS 4 or 5). The biopsies of these suspicious lesions resulted in a total of 30 malignant tumors and 32 benign lesions, respectively, yielding a 48.4% positive predictive value (PPV) of the biopsies. The mean and standard deviation of the lesion WO volume fraction of these 60 BI‐RADS 6 malignant tumors were first computed to establish a 99% sensitivity threshold value for malignant tumors, and then the biomarker was used to characterize the suspicious lesions. Using the biomarker would characterize all the malignant tumors as malignant, 12 out of the 32 benign lesions as benign, potentially resulting in a 24% improvement rate in the PPV of the biopsies (from 48.4% to 60%) and consequently a 22.5% reduction rate in the false‐positive rate of benign biopsies (from 51.6% to 40%). The lesion WO volume fraction biomarker could improve the computer‐based assessment of breast MRI by increasing the PPV of breast biopsies and reducing the number of unnecessary biopsies without compromising sensitivity. PACS number: 87.61.Tg, 87.19.Xj John Wiley and Sons Inc. 2015-09-08 /pmc/articles/PMC5690164/ /pubmed/26699291 http://dx.doi.org/10.1120/jacmp.v16i5.5187 Text en © 2015 The Authors. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/3.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Medical Imaging
Huang, Jie
Schafer, Sarah M.
Aben, Gerald R.
Hoisington, Lori A.
Using lesion washout volume fraction as a biomarker to improve suspicious breast lesion characterization
title Using lesion washout volume fraction as a biomarker to improve suspicious breast lesion characterization
title_full Using lesion washout volume fraction as a biomarker to improve suspicious breast lesion characterization
title_fullStr Using lesion washout volume fraction as a biomarker to improve suspicious breast lesion characterization
title_full_unstemmed Using lesion washout volume fraction as a biomarker to improve suspicious breast lesion characterization
title_short Using lesion washout volume fraction as a biomarker to improve suspicious breast lesion characterization
title_sort using lesion washout volume fraction as a biomarker to improve suspicious breast lesion characterization
topic Medical Imaging
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690164/
https://www.ncbi.nlm.nih.gov/pubmed/26699291
http://dx.doi.org/10.1120/jacmp.v16i5.5187
work_keys_str_mv AT huangjie usinglesionwashoutvolumefractionasabiomarkertoimprovesuspiciousbreastlesioncharacterization
AT schafersarahm usinglesionwashoutvolumefractionasabiomarkertoimprovesuspiciousbreastlesioncharacterization
AT abengeraldr usinglesionwashoutvolumefractionasabiomarkertoimprovesuspiciousbreastlesioncharacterization
AT hoisingtonloria usinglesionwashoutvolumefractionasabiomarkertoimprovesuspiciousbreastlesioncharacterization